Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma (Q38244025)

31 August 2017

Percutaneous coronary intervention and atrial fibrillation: the triple therapy dilemma (English)

1 reference

31 August 2017

0 references

2

Dominick J Angiolillo

1 reference

31 August 2017

Jung Rae Cho

1

1 reference

PubMed ID

25164314

31 August 2017

language of work or name

1 reference

1 February 2015

1 reference

Journal of Thrombosis and Thrombolysis

31 August 2017

1 reference

31 August 2017

39

1 reference

31 August 2017

203-208

1 reference

31 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s11239-014-1132-z

31 August 2017

0 references

cites work

Antithrombotic therapy in the elderly

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Management of antiplatelet and anticoagulant therapy in patients with atrial fibrillation in the setting of acute coronary syndromes or percutaneous coronary interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Effect of clopidogrel added to aspirin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the Registro Regionale Angioplastiche Emilia-Romagna Registry).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

"Triple therapy" rather than "triple threat": a meta-analysis of the two antithrombotic regimens after stent implantation in patients receiving long-term oral anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Dabigatran versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Apixaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Edoxaban versus warfarin in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Antiplatelet and anticoagulant therapy for atherothrombotic disease: the role of current and emerging agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-014-1132-Z

Rationale and design of The Intracoronary Stenting and Antithrombotic Regimen—Testing of a six-week versus a six-month clopidogrel treatment Regimen In Patients with concomitant aspirin and oraL anticoagulant therapy following drug-Eluting stenting

21 January 2018

1 reference

12 December 2020

In-hospital management and outcome of patients on warfarin undergoing coronary stent implantation: results of the multicenter, prospective WARfarin and coronary STENTing (WAR-STENT) registry

1 reference

12 December 2020

Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1007/S11239-014-1132-Z

Identifiers

DOI

1 reference

31 August 2017

1 reference

PubMed ID

25164314